Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

June 17, 2022 00:37:25
Episode Cover

Life-Threatening Asthma

Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.  Of these, up to 50,000 may require...

Listen

Episode 0

June 19, 2017 00:17:50
Episode Cover

Angiotensin II for Vasodilatory Shock?

This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial.  Mike was one of the co-authors on this impressive publication and gives...

Listen

Episode 0

February 01, 2022 00:20:19
Episode Cover

EM-STAT!

Resuscitating the sick patient and providing ongoing critical care is incredibly challenging in critical access locations and resource limited EDs.  In this podcast, we...

Listen